Expansion of Discreet Ketamine

Discreet Ketamine, a leading provider of at-home ketamine-assisted therapy in South Florida, has announced a significant expansion of its services to meet growing demand for innovative mental health treatments across Palm Beach County and the broader region.

Growing Demand for Treatment-Resistant Care

The expansion comes in response to a sustained increase in patient interest from individuals living with treatment-resistant depression, anxiety, PTSD, and certain chronic pain conditions. As awareness of ketamine's therapeutic potential has grown, so has demand for reputable, medically supervised options that do not require a clinic visit.

Discreet Ketamine's model has resonated particularly with patients who have struggled to find relief from conventional treatments. To qualify for care, patients must have tried at least one other treatment without adequate relief, and undergo medical screening that excludes individuals with conditions such as uncontrolled hypertension, unstable cardiovascular disease, or severe pulmonary disease.

What the Practice Actually Offers

Unlike clinics that administer IV ketamine infusions or the FDA-approved nasal spray esketamine (Spravato), Discreet Ketamine takes a different approach: medically prescribed sublingual ketamine rapid dissolve tablets, taken at home under the supervision of a trusted companion or peer. The practice does not operate a brick-and-mortar treatment center. Every patient is treated in the comfort of their own residence, with all clinical interaction conducted via private, HIPAA-secure, non-recorded video consultations.

Each session begins with the patient placing the prescribed dose under the tongue. A trusted companion is required to be present throughout the experience for safety, and the platform incorporates real-time distress detection with instant alerts and 24/7 access to a crisis line. Patients are instructed not to drive for at least five hours after a session, and the protocols are designed around a safety-first philosophy.

What the Expansion Includes

The expansion has focused on extending capacity and refining the patient experience without changing the at-home, telehealth-driven model that defines the practice. Key elements include expanded clinical capacity to reduce wait times, refined onboarding for new patients, deeper integration with each patient's existing mental health providers when appropriate, and continued investment in the safety platform that monitors patients during their sessions.

The practice continues to focus exclusively on what it does well rather than diversifying into modalities like IV infusions or Spravato. Leadership has emphasized that the at-home sublingual model offers significant advantages in accessibility, comfort, and cost compared to clinic-based alternatives, and the practice is committed to that approach.

The Discreet Ketamine Difference

Discreet Ketamine distinguishes itself through its emphasis on comprehensive psychiatric care rather than a transactional ketamine-only approach. Each patient undergoes a thorough psychiatric and medical evaluation before treatment, and the prescribing physicians work to integrate ketamine sessions into a broader treatment plan that may include psychotherapy and ongoing mental health care from the patient's existing providers.

The practice's name reflects both its commitment to patient privacy and the understanding that many individuals seeking mental health treatment prefer discretion. Treating patients in their own homes, rather than in a clinical setting, supports that goal while also reducing the practical barriers that prevent many people from following through on care.

Serving South Florida

With its expanded capacity, Discreet Ketamine is positioned to serve patients throughout South Florida, including Palm Beach, Broward, and Miami-Dade counties. The practice does not require travel to a clinic and operates entirely through telehealth consultations and home-based sessions, making it an option for patients who cannot easily access in-person ketamine providers due to mobility, scheduling, or geographic constraints.